Anti-NDUFA13 antibodies are used in the immunodetection of the protein NADH:ubiquinone oxidoreductase subunit A13. In humans, the canonical protein has a reported length of 144 amino acid residues and a mass of 16.7 kDa. Its subcellular localization is in the nucleus and mitochondria. Up to 2 different isoforms have been reported for this protein. It is found to be widely expressed, with highest expression in the heart, skeletal muscle, liver, kidney and placenta. A member of the Complex I NDUFA13 subunit protein family, NDUFA13 is reported to be an accessory subunit the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Synonyms for this target antigen include CDA016, CGI-39, GRIM-19, GRIM19, MC1DN28, and B16.6. NDUFA13 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Over 60 citations in the literature describe the use of NDUFA13 antibodies in research. Western Blot is a widely used application for these antibodies. In addition, Immunohistochemistry is also a common application.